Perrigo's Brazilian Depositary Receipt Listed on B3 Exchange
TradingView covers Perrigo's unsponsored BDR on Brazil's B3, offering financials and analyst estimates side by side.
If you've ever wondered how to track a US-linked pharmaceutical stock through a Brazilian exchange, Perrigo Company PLC's unsponsored Brazilian Depositary Receipt — ticker P1RG34 — is a solid case study. Listed on Brazil's B3 exchange, this BDR gives investors exposure to Perrigo's performance without directly buying shares on a US market.
TradingView's dedicated page for P1RG34 pulls together a pretty comprehensive financial snapshot. You'll find income statement data, balance sheet figures, and cash flow breakdowns — all laid out so you can quickly compare what the company actually reported against what analysts were expecting. That side-by-side view is genuinely useful when you're trying to gauge whether a company is beating, meeting, or missing Wall Street's projections.
Read more Strategy's June 30 Ex-Dividend Date: What Investors Should Know →
For the uninitiated, a Brazilian Depositary Receipt works a lot like an American Depositary Receipt (ADR), just flipped. Instead of a foreign company listing on a US exchange, a foreign company's shares are represented on a Brazilian exchange. The "unsponsored" tag here means Perrigo itself isn't directly behind the BDR program — a third-party financial institution set it up, which can occasionally affect how smoothly information flows between the company and BDR holders.
TradingView is upfront that everything on the page is purely informational. The platform explicitly notes that none of the data constitutes investment advice, and it encourages users to do their own homework before making any moves. That's a reasonable reminder, especially when you're dealing with a cross-border instrument that layers currency risk on top of regular company risk.
Continue reading at TradingView
